Treatment of Chronic Hepatitis C With PegIntron [peginterferon alfa-2b] Injector and Rebetol [ribavirin] According to German Law (67 Abs 6 AMG).

Trial Profile

Treatment of Chronic Hepatitis C With PegIntron [peginterferon alfa-2b] Injector and Rebetol [ribavirin] According to German Law (67 Abs 6 AMG).

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Nov 2013

At a glance

  • Drugs Peginterferon alfa-2b; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Sponsors Schering-Plough
  • Most Recent Events

    • 31 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Dec 2008 Planned number of patients changed to 2211.
    • 17 Dec 2008 Planned end date changed from 1 Jan 2009 to 1 Jun 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top